Loading...
Loading...
Browse all stories on DeepNewz
VisitPrediction Markets
Name | Option type | Quality (1-5)↓ | Topics | Created | |
---|---|---|---|---|---|
Hims & Hers Health, Inc. stock recovers to pre-announcement level by Q1 2025? | Binary | 3 | 13 days ago | ||
Eli Lilly's Zepbound sales increase by more than 20% in Q1 2025? | Binary | 2 | 13 days ago | ||
Ro faces legal challenges over Zepbound distribution by end of 2024? | Binary | 2 | 13 days ago | ||
Eli Lilly's Zepbound market share in weight-loss drugs by end of 2025? | Categorical | 2 | 13 days ago | ||
Leader in GLP-1 weight-loss drug market by end of 2025? | Categorical | 2 | 13 days ago | ||
Impact of Ro's partnership with Eli Lilly on customer base by mid-2025? | Categorical | 2 | 13 days ago |